Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cindy E Neunert

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Blood Advances|June 27, 2019
Romiplostim for the management of pediatric immune thrombocytopenia: drug development and current practiceCindy E Neunert, Melissa J Rose
Pediatric Blood & Cancer|October 16, 2008
6-Mercaptopurine: teaching an old drug new tricksCindy E Neunert, George R Buchanan
Hematology. American Society of Hematology. Education Program|December 10, 2013
Is anti-D immunoglobulin still a frontline treatment option for immune thrombocytopenia?Jenny M Despotovic, Cindy E Neunert
British Journal of Haematology|August 27, 2024
Lightening the load for paediatric ITP: The importance of health-related quality of lifeCindy E Neunert, Michele P Lambert
Lancet (London, England)|August 2, 2015
Thrombopoietin-receptor agonists in children with immune thrombocytopeniaCindy E Neunert, Rachael F Grace
Current Opinion in Hematology|July 6, 2016
Controversies in the treatment of immune thrombocytopeniaAdam Cuker, Douglas B Cines, Cindy E Neunert
The Journal of Pediatrics|October 3, 2018
Intravenous Immunoglobulin Versus Anti-D Immunoglobulin: When Better Treatment May Not Be the Best TreatmentSarah H O'Brien, Jenny M Despotovic, Cindy E Neunert
Pediatric Blood & Cancer|May 29, 2008
Severe chronic refractory immune thrombocytopenic purpura during childhood: a survey of physician managementCindy E Neunert, Brianna C Bright, George R Buchanan
Frontiers in Medicine|November 10, 2018
Neonatal ECMOCornelia Heleen Van Ommen, Cindy E Neunert, Meera B Chitlur
Pediatric Blood & Cancer|January 24, 2017
Patterns and influences in health-related quality of life in children with immune thrombocytopenia: A study from the Dallas ITP CohortAdolfo Flores, Robert J Klaassen, George R Buchanan, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Blood Advances|June 27, 2019
Romiplostim for the management of pediatric immune thrombocytopenia: drug development and current practiceCindy E Neunert, Melissa J Rose
Pediatric Blood & Cancer|October 16, 2008
6-Mercaptopurine: teaching an old drug new tricksCindy E Neunert, George R Buchanan
Hematology. American Society of Hematology. Education Program|December 10, 2013
Is anti-D immunoglobulin still a frontline treatment option for immune thrombocytopenia?Jenny M Despotovic, Cindy E Neunert
British Journal of Haematology|August 27, 2024
Lightening the load for paediatric ITP: The importance of health-related quality of lifeCindy E Neunert, Michele P Lambert
Lancet (London, England)|August 2, 2015
Thrombopoietin-receptor agonists in children with immune thrombocytopeniaCindy E Neunert, Rachael F Grace
Current Opinion in Hematology|July 6, 2016
Controversies in the treatment of immune thrombocytopeniaAdam Cuker, Douglas B Cines, Cindy E Neunert
The Journal of Pediatrics|October 3, 2018
Intravenous Immunoglobulin Versus Anti-D Immunoglobulin: When Better Treatment May Not Be the Best TreatmentSarah H O'Brien, Jenny M Despotovic, Cindy E Neunert
Pediatric Blood & Cancer|May 29, 2008
Severe chronic refractory immune thrombocytopenic purpura during childhood: a survey of physician managementCindy E Neunert, Brianna C Bright, George R Buchanan
Frontiers in Medicine|November 10, 2018
Neonatal ECMOCornelia Heleen Van Ommen, Cindy E Neunert, Meera B Chitlur
Pediatric Blood & Cancer|January 24, 2017
Patterns and influences in health-related quality of life in children with immune thrombocytopenia: A study from the Dallas ITP CohortAdolfo Flores, Robert J Klaassen, George R Buchanan, et al.
Pageof 4